Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13938)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2019 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu XN, Cui DN, Li YF, Liu YH, Liu G, Liu L. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World J Gastroenterol 2019; 25(30): 4199-4212 [PMID: 31435173 DOI: 10.3748/wjg.v25.i30.4199] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v25/i30/4199.htm |
| Number | Citing Articles |
| 1 |
Chenbin Liu, Han Wu, Yinqi Mao, Wei Chen, Shuying Chen. Exosomal microRNAs in hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01941-9
|
| 2 |
Chao-Wei Lee, Ming-Chin Yu, Gigin Lin, Jo-Chu Chiu, Meng-Han Chiang, Chang-Mu Sung, Yi-Chung Hsieh, Tony Kuo, Cheng-Yu Lin, Hsin-I Tsai. Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01885-w
|
| 3 |
Hantao Zhang, Xun Gong, Min Tang. Methodologies of Multi-Omics Data Integration and Data Mining. Translational Bioinformatics 2023; 19: 77 doi: 10.1007/978-981-19-8210-1_5
|
| 4 |
Gaoyang Chen, Zhisheng Zhang, Yan Li, Lu Wang, Yanqing Liu, Qin Yuan. LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/3624306
|
| 5 |
Yuchen Hu, Shan Ye, Qian Li, Tiantian Yin, Jing Wu, Jie He. <p>Quantitative Proteomics Analysis Indicates That Upregulation of lncRNA HULC Promotes Pathogenesis of Glioblastoma Cells</p>. OncoTargets and Therapy 2020; : 5927 doi: 10.2147/OTT.S252915
|
| 6 |
Binglin Cheng, Jingdong Tian, Yuhan Chen. Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma. Aging 2021; 13(12): 16124 doi: 10.18632/aging.203139
|
| 7 |
Pooja Basthi Mohan, Rajiv Lochan, Shiran Shetty. Biomarker in Hepatocellular Carcinoma. Indian Journal of Surgical Oncology 2024; doi: 10.1007/s13193-023-01858-x
|
| 8 |
Kai Sun, Haochen Wang, Dongyuan Zhang, Yupeng Li, Lei Ren. Depleting circ_0088364 restrained cell growth and motility of human hepatocellular carcinoma via circ_0088364-miR-1270-COL4A1 ceRNA pathway. Cell Cycle 2022; 21(3): 261 doi: 10.1080/15384101.2021.2016196
|
| 9 |
Haoting Shi, Jingxuan Huang, Xue Wang, Runchuan Li, Yiqing Shen, Bowen Jiang, Jinjun Ran, Rong Cai, Fang Guo, Yufei Wang, Gang Ren. Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1157841
|
| 10 |
Courtney E. Hershberger, Alejandro I. Rodarte, Shirin Siddiqi, Amika Moro, Lou‐Anne Acevedo‐Moreno, J. Mark Brown, Daniela S. Allende, Federico Aucejo, Daniel M. Rotroff. Salivary metabolites are promising non‐invasive biomarkers of hepatocellular carcinoma and chronic liver disease. Liver Cancer International 2021; 2(2): 33 doi: 10.1002/lci2.25
|
| 11 |
Zhenxiao Wang, Hanjiao Qin, Shui Liu, Jiyao Sheng, Xuewen Zhang. Precision diagnosis of hepatocellular carcinoma. Chinese Medical Journal 2023; 136(10): 1155 doi: 10.1097/CM9.0000000000002641
|
| 12 |
Nadia Ahmed, Kevin Benny, Sohail Siraj, Hufsa Ali, Riyaz Basha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 287 doi: 10.1016/B978-0-323-99283-1.00002-1
|
| 13 |
Jia-Mei Dong, Rui-Qi Wang, Ning-Ning Yuan, Jia-Hao Guo, Xin-Yang Yu, Ang-Hui Peng, Jia-Yi Cai, Lei Xue, Zhi-Ling Zhou, Yi-Hao Sun, Ying-Yin Chen. Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1160544
|
| 14 |
Song Jiang, Ting Wang, Kun-He Zhang. Data-driven decision-making for precision diagnosis of digestive diseases. BioMedical Engineering OnLine 2023; 22(1) doi: 10.1186/s12938-023-01148-1
|
| 15 |
Athanasios Armakolas, Vasiliki Dimopoulou, Adrianos Nezos, George Stamatakis, Martina Samiotaki, George Panayotou, Maria Tampaki, Martha Stathaki, Spyridon Dourakis, John Koskinas. Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma. Current Issues in Molecular Biology 2022; 44(10): 4714 doi: 10.3390/cimb44100322
|
| 16 |
Jiaxuan Xu, Yawen Cao, Xiangyan Wu, Yue Cheng, Xin Zhang. Neutrophil extracellular traps-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in hepatocellular carcinoma. Journal of Radiation Research and Applied Sciences 2023; 16(2): 100577 doi: 10.1016/j.jrras.2023.100577
|
| 17 |
Nabil Mohie Abdel-Hamid, Shimaa Ali Abass. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_148-1
|
| 18 |
Chuanxing Wu, Xiaosheng Qi, Zhengjun Qiu, Guilong Deng, Lin Zhong. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC. Aging 2021; 13(18): 22148 doi: 10.18632/aging.203494
|
| 19 |
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World Journal of Gastroenterology 2022; 28(1): 140-153 doi: 10.3748/wjg.v28.i1.140
|
| 20 |
Yibin Che, Ge Wang, Qiang Xia. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.937310
|
| 21 |
N. Merchante, M. Rodríguez-Fernández, J. A. Pineda. Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies. Current HIV/AIDS Reports 2020; 17(1): 6 doi: 10.1007/s11904-019-00475-0
|
| 22 |
Salwa H. Gomaa, Mona M. Abaza, Hoda A. Elattar, Gamal A. Amin, Doaa M. Elshahawy. Soluble cluster of differentiation 26/soluble dipeptidyl peptidase-4 and glypican-3 are promising serum biomarkers for the early detection of Hepatitis C virus related hepatocellular carcinoma in Egyptians. Arab Journal of Gastroenterology 2020; 21(4): 224 doi: 10.1016/j.ajg.2020.04.016
|
| 23 |
Lang-Qing Sheng, Jia-Rong Li, Hao Qin, Ling Liu, Da-Dong Zhang, Qi Zhang, Meng-Li Huang, Xiao-Li Li, Xiao-Ya Xu, Yang-Nian Wei, Zi-Shuo Chen, Hui Luo, Ji-Yang Zhang, Cheng-Hui Zhou, Hao Chen, Ze-Guo Chen, Fu-Gen Li, Nian-Feng Li. Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis. World Journal of Gastrointestinal Oncology 2020; 12(10): 1195-1208 doi: 10.4251/wjgo.v12.i10.1195
|
| 24 |
Binyu Zhao, Shanshan Hu, Qingqing Xiao, Sinuo Fan, Xizhi Yu, Chunxue Li, Peihong Dong, Jianjian Zheng. Expression of NOTCH receptors and ligands and prognosis of hepatocellular carcinoma. Biomarkers in Medicine 2020; 14(17): 1631 doi: 10.2217/bmm-2020-0138
|
| 25 |
Liping Zhao, Jiahui Shi, Lei Chang, Yihao Wang, Shu Liu, Yuan Li, Tao Zhang, Tao Zuo, Bin Fu, Guibin Wang, Yuanyuan Ruan, Yali Zhang, Ping Xu. Serum-Derived Exosomal Proteins as Potential Candidate Biomarkers for Hepatocellular Carcinoma. ACS Omega 2021; 6(1): 827 doi: 10.1021/acsomega.0c05408
|
| 26 |
Antonia Reale, Tiffany Khong, Rong Xu, Maoshan Chen, Sridurga Mithraprabhu, Nicholas Bingham, Andrew Spencer, David W. Greening. Proteomic Profiling. Methods in Molecular Biology 2021; 2261: 151 doi: 10.1007/978-1-0716-1186-9_10
|
| 27 |
Aroosha Raja, Farhan Haq. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications. Journal of Cancer Research and Clinical Oncology 2022; 148(1): 15 doi: 10.1007/s00432-021-03826-w
|
| 28 |
Emma Butaye, Nicky Somers, Lorenz Grossar, Nele Pauwels, Sander Lefere, Lindsey Devisscher, Sarah Raevens, Anja Geerts, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2024; 59(1): 23 doi: 10.1111/apt.17748
|
| 29 |
Zhifeng Ye, Lu Wang. Construction of A Novel Prognostic Model with Molecular Targets for Hepatocellular Carcinoma Based on Bioinformatics Applications. Journal of Biomedical Nanotechnology 2023; 19(2): 206 doi: 10.1166/jbn.2023.3520
|
| 30 |
Md Mamunur Rashid, Rency S. Varghese, Yuansong Ding, Habtom W. Ressom. Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies. Metabolites 2023; 13(10): 1047 doi: 10.3390/metabo13101047
|
| 31 |
Yotsawat Pomyen, Anuradha Budhu, Jittiporn Chaisaingmongkol, Marshonna Forgues, Hien Dang, Mathuros Ruchirawat, Chulabhorn Mahidol, Xin Wei Wang, Benjarath Pupacdi, Siritida Rabibhadana, Kannikar Phonphutkul, Nirush Lertprasertsuke, Anon Chotirosniramit, Chirayu U. Auewarakul, Teerapat Ungtrakul, Vajarabhongsa Budhisawasdi, Chawalit Pairojkul, Suleeporn Sangrajang, Curtis C. Harris, Christopher A. Loffredo, Robert Wiltrout. Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91560-1
|
| 32 |
P. Gunasekhar, S. Vijayalakshmi. Optimal biomarker selection using adaptive Social Ski-Driver optimization for liver cancer detection. Biocybernetics and Biomedical Engineering 2020; 40(4): 1611 doi: 10.1016/j.bbe.2020.10.005
|
| 33 |
Fanghua Chen, Junming Wang, Yingcheng Wu, Qiang Gao, Shu Zhang. Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.822449
|
| 34 |
Tommy Ivanics, Emmanuel Salinas-Miranda, Phillipe Abreu, Farzad Khalvati, Khashayar Namdar, Xin Dong, Dominik Deniffel, Andre Gorgen, Lauren Erdman, Kartik Jhaveri, Masoom Haider, Patrick Veit-Haibach, Gonzalo Sapisochin. A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker. Transplantation 2021; 105(11): 2435 doi: 10.1097/TP.0000000000003605
|
| 35 |
Jinhao Liu, Jikun Wang, Xueqian Ma, Yang Feng, Yanlei Chen, Yanping Wang, Dong Xue, Shifeng Qiao. <p>Study of the Relationship Between Serum Amino Acid Metabolism and Lymph Node Metastasis in Patients with Colorectal Cancer</p>. OncoTargets and Therapy 2020; : 10287 doi: 10.2147/OTT.S273107
|
| 36 |
Christa Buechler, Charalampos Aslanidis. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(5): 158658 doi: 10.1016/j.bbalip.2020.158658
|
| 37 |
Iuliana Nenu, Teodora Maria Toadere, Ioan Topor, Andra Țichindeleanu, Daniela Andreea Bondor, Șerban Ellias Trella, Zeno Sparchez, Gabriela Adriana Filip. Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View. Biomedicines 2023; 11(10): 2623 doi: 10.3390/biomedicines11102623
|
| 38 |
Qiangnu Zhang, Weibin Hu, Lingfeng Xiong, Jin Wen, Teng Wei, Lesen Yan, Quan Liu, Siqi Zhu, Yu Bai, Yuandi Zeng, Zexin Yin, Jilin Yang, Wenjian Zhang, Meilong Wu, Yusen Zhang, Gongze Peng, Shiyun Bao, Liping Liu. IHGA: An interactive web server for large-scale and comprehensive discovery of genes of interest in hepatocellular carcinoma. Computational and Structural Biotechnology Journal 2023; 21: 3987 doi: 10.1016/j.csbj.2023.08.003
|
| 39 |
Yanteng Zhao, Lei Zhao, Huifang Jin, Ying Xie, Liyinghui Chen, Wei Zhang, Lanlan Dong, Lianglu Zhang, Yue Huang, Kangkang Wan, Qiankun Yang, Shaochi Wang. Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma. Epigenetics 2024; 19(1) doi: 10.1080/15592294.2023.2299044
|
| 40 |
Guojun Hou, Dongyang Ding, Tao Tian, Wei Dong, Dapeng Sun, Gang Liu, Yuan Yang, Weiping Zhou. Metabolomics‐based classification reveals subtypes of hepatocellular carcinoma. Molecular Carcinogenesis 2022; 61(11): 989 doi: 10.1002/mc.23455
|
| 41 |
Yasunari Matsuzaka, Ryu Yashiro. Applications of Deep Learning for Drug Discovery Systems with BigData. BioMedInformatics 2022; 2(4): 603 doi: 10.3390/biomedinformatics2040039
|
| 42 |
Ying Hou, Yipeng Tang, Chi Ma, Jingbo Yu, Youpeng Jia. Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma. Digestive and Liver Disease 2023; 55(6): 799 doi: 10.1016/j.dld.2022.12.001
|
| 43 |
Modibo Coulibaly, Adama Kondé, Djibril Traoré, Ousmane Bah, Valentin Sagara, Bakary Maiga. Assessment of alpha-fetoprotein clinical performances in the diagnosis of the hepatocellular carcinoma at Sominé DOLO hospital of Mopti. International Journal of Clinical Biochemistry and Research 2023; 10(2): 163 doi: 10.18231/j.ijcbr.2023.028
|
| 44 |
Po-Shuan Huang, Cheng-Chih Chang, Chia-Siu Wang, Kwang-Huei Lin. Functional roles of non-coding RNAs regulated by thyroid hormones in liver cancer. Biomedical Journal 2021; 44(3): 272 doi: 10.1016/j.bj.2020.08.009
|
| 45 |
Zhiyu Xiong, Ping Chen, Mengqin Yuan, Lichao Yao, Zheng Wang, Pingji Liu, Yingan Jiang. Integrated Bioinformatics and Validation Reveal IFI27 and Its Related Molecules as Potential Identifying Genes in Liver Cirrhosis. Biomolecules 2023; 14(1): 13 doi: 10.3390/biom14010013
|
| 46 |
Felix Lu, Connor Ott, Prabha Bista, Xuanyong Lu. Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC). Diagnostics 2024; 14(7): 725 doi: 10.3390/diagnostics14070725
|